Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by ANALIAS00on Jan 28, 2021 10:16am
125 Views
Post# 32408601

RE:RE:RE:Dumping 20M shares and keeping 10M warrants @$3.18

RE:RE:RE:Dumping 20M shares and keeping 10M warrants @$3.18So if I understand the facts correctly: - No analyst are interested to provide serious and full detail report on THTX - No analyst see THTX's future as bright as we would like to - The buyers already sold their shares so we can only come to conclusion they do not believe in THTX's furure - Because of this horrible deal we must understand that nobody believe in THTX's future including THTX themself. - Even before the horrible deal THTX's market cap was clearly behind all other similar biotech that only prove that no investers believes in THTX's future So we, old sharolders, are the only one that believed in THTX. We would be right and the world would be wrong ? I passed from a believer to very sceptical. I dont believe no more, I can only hope as many said before. I bought again recently at few occasions form 2.53 (can) to 3.00. I was happy when SP reached 4.16. I dont feel like going back to read that PR. Wondering if it started by "THERATECHNOLIGIES are please to announce...". I wonder if highfives were VIRTUALLY shared at THERATECNOLOGIES after this deal was signed. Facts and market telling us that no one wants to speculate on THTX. Even THTX seems having problem to believe in themself. I trusted THTX management. Sorry guys but I only find confort thinking that the few experts that you are were wrong to. :o)
palinc2000 wrote:

Comments:
1-The number of shares issued is 16 million not 19 million 

2-Apparently there are about  10 million Units in the hands of 3 presumed to be long term holders
3- That would leave about 6 million shares in the hands of retail /short term holders of which approximaty 2.5-3.0 have sold already and kept the Warrants as you explained
4- Thus there are still some 3 million shares held by the original acquirer and I also think most of them will get rid of the shares in any subsequent spikes in the SP 

5-Yes it is an atrocious deal for legacy shareholders



<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse